Details of the Drug Formulations

General Information of Drug (ID: DM6VZFQ)

• Drug Name: Pirfenidone Drug Info
• Synonyms: Deskar; Esbriet; Pirespa; Pirfenidona; Pirfenidonum; AMR 69; P 2116; AMR-69; F-647; KS-5041; Pirfenidona [INN-Spanish]; Pirfenidone (Deskar); Pirfenidone [USAN:INN]; Pirfenidonum [INN-Latin]; S-7701; Pirfenidone (JAN/USAN/INN); 5-Methyl-1-phenyl-1H-pyridin-2-one; 5-Methyl-1-phenyl-2(1H)-pyridone; 5-Methyl-1-phenyl-2-(1H)-pyridone; 5-methyl-1-phenylpyridin-2(1H)-one; 5-methyl-1-phenylpyridin-2-one

Indication

Disease Entry	ICD 11	Status	REF
Idiopathic pulmonary fibrosis	CB03.4	Approved	[1]

• Cross-matching ID:
  PubChem CID: 40632
  ChEBI ID: CHEBI:32016
  CAS Number: 53179-13-8
  TTD ID: D02WCI
  INTEDE ID: DR1299
  ACDINA ID: D00536

Full List of Drug Formulations Containing This Drug

Pirfenidone 801 mg tablet

Company	Formulation ID	FDA Description
Genentech	F17322	Magnesium stearate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Povidone k30; Silicon dioxide; Microcrystalline cellulose; Polyvinyl alcohol, unspecified

Pirfenidone 267 mg tablet

Company	Formulation ID	FDA Description
Genentech	F17321	Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Povidone k30; Silicon dioxide; Microcrystalline cellulose; Polyvinyl alcohol, unspecified

Pirfenidone 267 mg capsule

Company	Formulation ID	FDA Description
Genentech	F17320	Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Gelatin, unspecified; Microcrystalline cellulose; Povidone, unspecified; Shellac

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7532).